SkinPen Precision, engineered in the USA, has garnered FDA clearance in 2018 and boasts over 90 validation studies. It is a state-of-the-art skin remodeling device designed for various aesthetic and medical purposes.
DUBIMED Medical Supplies Trading LLC is proud to collaborate with Crown Aesthetics to distribute SkinPen Precision in the United Arab Emirates, Qatar, and Oman. Crown Aesthetics, a distinguished division of Crown Laboratories, Inc., brings SkinPen, the pioneering FDA-cleared microneedling device, to the Gulf States. This partnership enhances the accessibility of this globally recognized skin remodeling tool to healthcare professionals and customers across these regions.
Invalid embed URL: https://youtu.be/Cq3sIO5Kleo
Andy Moulton, Vice President of Sales, International for Crown Aesthetics, expressed the company’s dedication to the Middle East’s growth and praised DUBIMED’s capability to promote its brands effectively. Safi Rajab, CEO of DUBIMED, highlighted their 37-year leadership in the Gulf Cooperation Council and their commitment to introducing advanced aesthetic medical solutions. Adding Crown’s products to its esteemed global brand portfolio signifies DUBIMED’s pursuit of excellence and its aim to elevate Crown’s brand presence in the Gulf.
SkinPen Precision, engineered in the USA, has garnered FDA clearance in 2018 and boasts over 90 validation studies. It is a state-of-the-art skin remodeling device designed for various aesthetic and medical purposes. In the Gulf States, FDA-cleared SkinPen precision is utilized for Collagen Induction Therapy to address melasma, acne, and surgical scars. This microneedling system creates controlled micro-injuries to stimulate the body’s natural healing response, remodeling scar tissue effectively. Recognized for its safety and efficacy across all Fitzpatrick skin types, SkinPen offers minimal cellular damage and virtually no downtime for patients.
For over 37 years, DUBIMED Medical Supplies Trading LLC has been a trusted name in the Gulf Cooperation Council. With a steadfast commitment to providing cutting-edge aesthetic medical solutions, DUBIMED has solidified its position as a leader in the region. Their rich history, unwavering focus on quality, and dedication to innovation have allowed them to serve healthcare professionals and customers across the Gulf States with integrity and reliability.
DUBIMED’s partnership with Crown Aesthetics represents a significant step forward in their mission to offer premier medical supplies. By adding Crown’s renowned products, such as SkinPen Precision, to their portfolio, DUBIMED reinforces its commitment to providing high-caliber solutions to its clientele. This collaboration with Crown Aesthetics, known for its focus on rejuvenation and restoration, promises to further enhance DUBIMED’s reputation as a leading distributor of aesthetic medical products in the Gulf.
Crown Aesthetics, a division of Crown Laboratories, Inc., is dedicated to empowering leading practices worldwide. With a focus on delivering transformative results in rejuvenation and restoration, Crown Aesthetics offers a range of minimally invasive innovations. These include SkinPen®, MicroPen EVO™, BIOJUVE™, ProGen PRP® Eclipse, and VOTESSE®, each setting industry benchmarks for efficacy, safety, and innovation.
Crown Laboratories, Inc., the parent company of Crown Aesthetics, is a fully integrated global skincare company. Committed to enhancing the quality of life for consumers throughout their skincare journey, Crown Laboratories develops a diverse portfolio of aesthetic, premium, and therapeutic skincare products. With a presence in over 50 countries and consistent recognition on the Inc. 5000 Fastest Growing Privately Held Companies List, Crown Laboratories continues to lead in Dermatology and Aesthetics through its relentless pursuit of therapeutic excellence and enhanced patient outcomes.
Explore more articles you might find interesting
